62
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Safety evaluation of poly(lactic-co-glycolic acid)/poly(lactic-acid) microspheres through intravitreal injection in rabbits

, , &
Pages 3057-3068 | Published online: 24 Jun 2014

References

  • FouldsWMoseleyHEadieAMcNaughtEVitreal, retinal, and pigment epithelial contribution to the posterior blood–ocular barrierTrans Ophthalmol Soc UK198010033413426946627
  • GhateDEdelhauserHFOcular drug deliveryExpert Opin Drug Deliv20063227528716506953
  • Cunha-VazJGThe blood–ocular barriers: past, present, and futureDoc Ophthalmol1997931–21491579476613
  • KearnsVRWilliamsRLDrug delivery systems for the eyeExpert Rev Med Devices20096327729019419285
  • TanitoMLiFElliottMHDittmarMAndersonREProtective effect of TEMPOL derivatives against light-induced retinal damage in ratsInvest Ophth Vis Sci200748419001905
  • RongXMoXRenTNeuroprotective effect of erythropoietin-loaded composite microspheres on retinal ganglion cells in ratsEur J Pharm Sci201143433434221621611
  • FrogerNCadettiLLorachHTaurine provides neuroprotection against retinal ganglion cell degenerationPLoS ONE2012710e4201723115615
  • GhateDEdelhauserHFBarriers to glaucoma drug deliveryJ Glaucoma200817214715618344762
  • PrasadAGSchadluRApteRSIntravitreal pharmacotherapy: applications in retinal diseaseCompr Ophthalmol Update20078525926918201513
  • WadhwaSPaliwalRPaliwalSRVyasSNanocarriers in ocular drug delivery: an update reviewCurr Pharm Design2009152327242750
  • YasukawaTOguraYKimuraHSakuraiETabataYDrug delivery from ocular implantsExpert Opin Drug Deliv20063226127316506952
  • SinhaVTrehanABiodegradable microspheres for protein deliveryJ Control Release200390326128012880694
  • SoppimathKSAminabhaviTMKulkarniARRudzinskiWEBiodegradable polymeric nanoparticles as drug delivery devicesJ Control Release200170112011166403
  • KreuterJNanoparticulate systems in drug delivery and targetingJ Drug Target1995331711738705247
  • RongXYangSMiaoHEffects of erythropoietin–dextran microparticle-based PLGA/PLA microspheres on RGCsInvest Ophth Vis Sci2012531060256034
  • GengYYuanWWuFChenJHeMJinTFormulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregationJ Control Release2008130325926518620011
  • Andrieu-SolerCAubert-PouësselADoatMIntravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouseMol Vis2005111002101116319820
  • ShmueliRBOhnakaMMikiALong-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptideBiomaterials201334307544755123849876
  • JiangCMooreMJZhangXKlassenHLangerRYoungMIntravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucomaMol Vis2007131783179217960131
  • O’CallaghanJAssessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarkerBiomedical and environmental sciences: BES199141–21972061910596
  • PengYAngMFooSBiocompatibility and biodegradation studies of subconjunctival implants in rabbit eyesPLoS ONE201167e2250721799878
  • GiarmoukakisALabirisGSideroudiHBiodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: In vitro and in vivo evaluation. Preliminary resultsExp Eye Res2013112293623603320
  • DuvvuriSJanoriaKGPalDMitraAKControlled delivery of ganciclovir to the retina with drug-loaded poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitisJ Ocul Pharmacol Th2007233264274
  • MoriteraTOguraYYoshimuraNBiodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathyInvest Ophth Vis Sci1992331131253130
  • WoldemussieEWijonoMRuizGMüller cell response to laser-induced increase in intraocular pressure in ratsGlia200447210911915185390
  • KaplanHJStreileinJWStevensTRTransplantation immunology of the anterior chamber of the eye II. Immune response to allogeneic cellsJ Immunol19751153805810239065
  • StreileinJWOcular immune privilege: therapeutic opportunities from an experiment of natureNat Rev Immunol200331187988914668804
  • NiederkornJYSee no evil, hear no evil, do no evil: the lessons of immune privilegeNat Immunol20067435435916550198
  • Schewitz-BowersLPLeeRWDickADImmune mechanisms of intraocular inflammationExpert Rev Ophthalmol2010514358
  • ZhouRHoraiRSilverPBThe living eye “diarms” uncommitted autoreactive T cells by converting them to Foxp3+ regulatory cells following local antigen recognitionJ Immunol201218841742175022238462
  • RosolenSGKolomietsBVarelaOPicaudSRetinal electrophysiology for toxicology studies: applications and limits of ERG in animals and ex vivo recordingsExp Toxicol Pathol2008601173218294830